2000
DOI: 10.1016/s0378-1097(99)00661-8
|View full text |Cite
|
Sign up to set email alerts
|

Streptococcus mutans strain N produces a novel low molecular mass non-lantibiotic bacteriocin

Abstract: Streptococcus mutans strain N was shown to have bacteriocin production and immunity characteristics consistent with those of Group I mutacin-producing strains of S. mutans. The bacteriocin mutacin N was purified from agar cultures of S. mutans strain N using XAD and reversed phase chromatography. The molecular mass of mutacin N was 4806 Da and the entire 49 amino acid sequence was determined by N-terminal sequencing. Database searches indicate that mutacin N is a novel bacteriocin, but with some homology to th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
16
0

Year Published

2002
2002
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(16 citation statements)
references
References 17 publications
0
16
0
Order By: Relevance
“…In contrast, inactivation of nlmB did not appear to affect inhibitory activity against the same 66 strains ( Table 1). The above observations were corroborated when selected strains were tested by a modification of the standard deferred antagonism assay (2) in which the number of producer cells inoculated was standardized (15-l drop inoculum of an 18-h Todd-Hewitt broth culture adjusted to an optical density at 600 nm of 0.02). No significant differences in the sizes of inhibitory zones were detected between wild-type UA159 and the nlmB mutant UA⌬NlmB (Table 3).…”
mentioning
confidence: 73%
See 1 more Smart Citation
“…In contrast, inactivation of nlmB did not appear to affect inhibitory activity against the same 66 strains ( Table 1). The above observations were corroborated when selected strains were tested by a modification of the standard deferred antagonism assay (2) in which the number of producer cells inoculated was standardized (15-l drop inoculum of an 18-h Todd-Hewitt broth culture adjusted to an optical density at 600 nm of 0.02). No significant differences in the sizes of inhibitory zones were detected between wild-type UA159 and the nlmB mutant UA⌬NlmB (Table 3).…”
mentioning
confidence: 73%
“…The bacteriocins produced by the oral bacterium Streptococcus mutans are termed mutacins and are divided into two groups: (i) the lanthionine-containing (lantibiotic) mutacins (6,11,16,19,20) and (ii) the unmodified mutacins (2,21). While most bacteriocin activities characterized to date consist of a single active polypeptide, several two-component lantibiotic and nonlantibiotic bacteriocins have also been described, and these are dependent upon the collaborative activity of two polypeptides to exert their full antimicrobial activity (7,9,14,15,17,23).…”
mentioning
confidence: 99%
“…The inhibitory spectrum of mutacin N is distinctive compared to that of other mutacins in its ability to inhibit certain S. mutans strains (3,4). The resulting nlmT-deficient mutant, N⌬NlmT, failed to express any inhibitory activity ( Table 2), indicating that the NlmTE ABC transporter is also required for nonlantibiotic mutacin export in S. mutans strain N.…”
Section: Vol 187 2005 Notes 5037mentioning
confidence: 99%
“…The N-terminal sequence of mutacin N (group A) indicates that this peptide does not contain lanthionine or â-methyl lanthionine and that it has a strong match to a putative sugar-phosophotransferase enzyme from Acholeplasma florum [25]. One component of the non-lantibiotic bacteriocin mutacin IV [24] purified from strain UA140 (group A in the present study) shows a high degree of similarity to mutacin N despite the fact that the producing strains appear to be phylogenetically distinct.…”
Section: Discussionmentioning
confidence: 60%
“…More recently, this group has reported that the group I S. mutans strain UA140 produces, in addition to mutacin I, a twocomponent non-lantibiotic bacteriocin named mutacin IV [24]. Interestingly, the NlmB component of mutacin IV shares partial homology with mutacin N [25].…”
Section: Introductionmentioning
confidence: 99%